Role of calcium and magnesium at the cellular level in the increased release and synthesis of parathyroid hormone (PTH) in uremia;Role du calcium et du magnesium dans la secretion et la synthese de l'hormone parathyroidienne a l'echelon cellulaire

Presse Medicale

Volumn 27, Issue 26, 1998, Pages 1338-1348

  Fournier, A ^a   Yverneau Hardy, P ^a   Ghazali, A ^a   Oprisiu, R ^a   Hottelart, C ^a   Said, S ^a   Westeel, P F ^a   Achard, J M ^a   Pruna, A ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; MAGNESIUM; PARATHYROID HORMONE;

CALCIUM CELL LEVEL; CALCIUM TRANSPORT; HUMAN; HYPERPARATHYROIDISM; HYPOCALCEMIA; HYSTERESIS; PARATHYROID HORMONE RELEASE; PATHOPHYSIOLOGY; REVIEW; UREMIA; BIOSYNTHESIS; CHRONIC KIDNEY FAILURE; EXOCYTOSIS; GLOMERULUS FILTRATION RATE; METABOLISM; PARATHYROID GLAND; PHYSIOLOGY; SECRETION;

CALCIUM; EXOCYTOSIS; GLOMERULAR FILTRATION RATE; HUMANS; HYPERPARATHYROIDISM; KIDNEY FAILURE, CHRONIC; MAGNESIUM; PARATHYROID GLANDS; PARATHYROID HORMONE; UREMIA;

EID: 0032511471     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Martinez I, Saracho R, Montenegro J, Llach F. The importance of dietary calcium and phosphorus in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 1997 ; 29:496-502.
2. Silver J, Naveh-Many T. Regulation of parathyroid hormone synthesis and secretion. Semin Nephrol 1994 ; 14:175-94.
3. Kurokawa K. The kidney and calcium homeostasis. Kidney Int 1994 ; 45(suppl. 44):97-105.
4. Brown RC, Aston JP, Weeks I, Woodhead S. Circulating intact PTH measured by a two-site immunochemiluminometric assay. J Clin Endocr Metab 1987 ; 65:407-414.
5. Brossard JH, Cloutier M, Roy L, Lepage R, Gascon Barré M, d'Amour P. Accumulation of a non 1-84 molecular form of parathyroid hormone detected by intact PTH assay in renal failure : importance in the interpretation of PTH values. J Clin Endocr Metob 1996 ; 81:3923-9.
6. Brown EM. Homeostatic mechanism regulating extracellular and intracellular calcium metabolism. In "The parathyroids" edited by Bilezikian et al. Raven Press, New York, 1994 ; p. 15-54.
7. Schwarz P, Sorensen HA, Mc Nair P, Transbol I. Cica-clamp technique : a method for quantifying parathyroid hormone secretion : a sequential citrate and calcium clamp study. Eur J Clin Invest 1993 ; 23:546-53.
8. Aguilera-Tejero E, Rodriguez M, Sanchez J, Alenaden Y, Felsenfeld AJ. Hysteresis of the PTH-calcium curve during hypocalcemia in the dog: Effect of the rate and linearity of calcium decrease and sequential episodes of hypocalcemia. J Bone Miner Res 1996 ; 11:1226-33.
9. Sanchez J, Aguilera -Tejero E, Estepa JC, Almaden Y, Rodriguez A, Felsenfeld A. A reduced PTH response to hypocalcemia after a short period of hypercalcemia : a study in dogs. Kidney Int 1996 ; 50(suppl 57):S18-22.
10. Brown EM. Mechanism underlying the regulation of parathyroid hormone secretion in vivo and in vitro. Curr Opin Nephrol Hypertension 1993 ; 2:541-51.
11. Lewin E, Nielsen PK, Olgaard K. The calcium / parathyroid hormone concept of the parathyroid glands. Curr Opin Nephrol hypertension 1995 ; 4:324-33.
12. Goodman WG, Beilin TR, Slalusky I. In vivo assessment of calcium regulated parathyroid hormone release in secondary hyperparathyroidism. Kidney Int 1996 ; 50:1834-44.
13. Felsenfeld AJ, Rodriguez M. Parathyroid gland function in the hemodialysis patient. Semin Nephrol 1996 ; 9:303-9.
14. Rodriguez M, Caravaca F, Fernandez E, Borrego MJ, Felsenfeld AJ. Evidence for both abnormal set point of PTH stimulation by calcium and adaptation to serum calcium in hemodialysis patients with hyperparathyroidism. J Bone Miner Res 1997 ; 12:347-55.
15. Hardy-Yverneau P, Shenouda M, Morinière Ph et al. The dependency of calcium set point on basal plasma calcium in dialysis patients : a better explanation for discrepancies regarding its link with PTH secretion than methodological differences. Clin Nephrol (in press).
16. Brown EM, Gamba C, Riccardi R et al. Cloning and characterization of an extra-cellular Ca2+-sensing receptor from bovine parathyroid. Nature 1993 ; 366:575-80.
17. Ricardi D, Lee WS, Lee K Segre GV, Brown EM, Hebert SC. Localization of the extracellular calcium sensor and PTH/PTHrp receptor in rat kidney. Am J Physiol 1996 ; 271:F951-6.
18. Hebert SC. Extra-cellular calcium-sensing receptor implications for calcium and magnesium handling in the kidney. Kidney Int 1996 ; 50:2129-39.
19. House MC, Kohlmeier LA, Chattopadhyay N et al. Expression of an extracellular calcium sensing receptor in human and mouse bone Marrow. J Bone Miner Res 1997 ; 12:1959-70.
20. Hory B, Drüeke T. The parathyroid bone axis in uremia : new insights into old questions. Curr Opin Nephrol Hypertens 1997 ; 6:40-8.
21. Houiller P, Paillard M. Pathologie des récepteurs sensibles au calcium. Medecine thérapeutique 1996 ; 2:489-92.
22. Pearce SHS, Brown EM. The genetic basis of endocrine disease : Disorders of calcium ion sensing. J Clin Endocrinol Metab 1996 ; 81:2030-5.
23. Pollak MR, Brown EM, Estep HL, Seidman JG. Autosomal dominant hypocalcemia caused by a Ca 2+ sensing receptor gene mutation. Nature Genetics 1994 ; 8:303-7.
24. Brown AJ, Zhong M, Finch J, Morrissey J, Slatopolsky E. Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. Am J Physiol 1996 ; 270 (Renal Fluid Electrolytic Physiol. 39) : F454-60.
25. Hernandez A, Torres A, Concepcion MT, Salido E. Parathyroid gland calcium receptor gene expression is not regulated by increased dietary phosphorus in normal and renal failure rats. Nephrol Dial Transplant 1996 ; 11(suppl. 3):11-14.
26. Rogers K, Dunn C, Conklin R, Brown EM, Hebert S, Nemeth E. Calcium receptor mRNA levels in parathyroid glands and kidney of vitamin D deficient rats are not regulated by calcium or 1,25 (OH)2 vitamin D3. Endocrinology 1995 ; 136:499-504.
27. Bourdeau A, Souberbielle JC, Bonnet P, Herviaux P, Sachs C. Phospholipase A2 action and arachidonic acid metabolism in calcium mediated parathyroid hormone secretion. Endocrinology 1992 ; 130:1339-44.
28. Cohen J, Rahamimov R, Naveh Many T, Silver T. Calcium dynamics in bovine parathyroid cells. J Bone Miner Res 1996 ; 11(suppl 1) S418.
29. Fox J, Brown EM, Hebert SC, Rogers KV. Parathyroid gland calcium receptor gene expression is unaffected by chronic renal failure. Kidney Int 1993 ; 43:771-89.
30. Kifor O, Moore FD, Wang P, Hebert SC, Brown EM. Reduced immunostaining for extracellular Ca2+ sensing receptor in primary and uremic secondary hyperparathyroidism. Clin Endoc Metab 1996 ; 81:1598-1606.
31. Gogusev J, Duchambon P, Hory B, Giovanini M, Sarfati E, Drüeke T. Depressed expression of calcium receptor in parathyroid gland tissue of patients with primary and secondary uremic hyperparathyroidism. Kidney Int 1997 ; 51:328-36.
32. Tominaga Y, Sato K, Tanaka Y, Numano M, Uchida K, Takagi H. Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure. Clin Nephrol 1995 ; 44:S42-7.
33. Goodman WG, Veldhuis JD, Gales B, Juppner H, Salusky IB. Calcium-sensing by the parathyroidism in severe secondary hyperparathyroidism before parathyroidectomy. J Am Soc Nephrol 1997 ; 8:574 A.
34. Malberti F, Corradi B, Cosci P, Collaida F, Imbasciati E. Long term effects of intravenous calcitriol therapy on the control of hyperparathyroidism. Am J Kidney Dis 1996 ; 28:704-12.
35. Delmez JA, Tindira C, Grooms P, Dusso A, Windus WD, Slatopolsky E. Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role of increased sensitivity to calcium. J Clin Invest 1989 ; 83:1349-55.
36. Olsen M, Madsen JC, Sorensen LA Schwarz P, Ladefoged SD. Effect of alfacidol on the dynamic calcium -PTH relation in uremic hyperparathyroidism. Nephrol Dial Transplant 1995 ; 10:935.
37. Ouseph R, Moe SM, Leiser JD. Calcitriol and the parathyroid hormone ionized calcium curve: a comparison of methodologic approaches. J Am Soc Nephrol 1996 ; 7:499-505.
38. Silver J, Moallem E, Kilav R, Epstein E, Sela A, Naveh-Many T. New insights into the regulation of parathyroid hormone synthesis and secretion in chronic renal failure. Nephrol Dial Transplant 1996 ; 11(suppl. 3):2-5.
39. Naveh-Many T, Silver J. Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia and vitamin D in rat. Clin Invest 1990 ; 86:1313-19.
40. Roussanne MC, Hory B, Duchambon P, Souberbielle JC, Drüeke T, Bourdeau A. Persistance of Ca2+ sensing receptor expression in functionnally active long term human parathyroid cultures. J Bone Miner Res 1998 ; 13: (sous presse).
41. Brown AJ, Zhong M, Ritter CS, Brown EM, Slatopolsky E. Loss of calcium responsiveness in cultured parathyroid cells is associated with decreased expression of the calcium receptor. Am Soc Nephrol 1994 ; 5:877, [Abstract].
42. Hawa NS, O'Riordan JL, Farrow SM. Post-transcriptionnal regulation of bovine parathyroid hormone synthesis. Mol Endocrinol 1993 ; 10:43-9.
43. Slatopolsky E, Finch J, Kubodera K, Nishi Y, Brown A, Morissey J. Hypocalcemia overrides the suppressive effect of both 1,25 (OH)2 vitamin D3 and its analog 22-oxa calcitrion on prepro PTH in RNA synthesis and secretion. Am Soc Nephrol 1993 ; 47:23-42.
44. Clements MR, Johnson L, Fraser DB. A new mechanism for induced vitamin D deficiency in calcium derivation. Nature 1987 ; 324:62-5.
45. Llach F. Secondary hyperparathyroidism in renal failure : the trade off hypothesis revisited. Am J Kidney Dis 1995 ; 25:663-79.
46. Ritz E, Seidel A, Ramisch H, Szabo A, Bouillon R. Attenuated rise of 1,25(OH)2 vitamin D3 in response to parathyroid hormone in patients with incipient renal failure. Nephron 1991 ; 57:314-18.
47. Buschinsky DA. The contribution of acidosis to renal osteodystrophy. Kidney Int 1995 ; 47:1816-32.
48. Hsu CH, Patel S. Uremic plasma contains factors inhibiting 1 a hydroxylase activity. J Am Soc Nephrol 1992 ; 3:947-52.
49. Adler AJ, Ferran N, Berlyne GM. Effect of inorganic phosphate an serum ionized calcium concentration in vitro. A reassessment of the trade-off hypothesis. Kidney Int 1985 ; 28:932-5.
50. Kaye M. Hypocalcemia after an acute phosphate load is secondary to reduced calcium efflux from bone: studies in patients with minimal renal function and varying parathyroid activity. J Am Soc Nephrol 1995 ; 6:273-80.
51. Felsenfeld A, Machado L, Rodriguez M : The relationship between serum calcitonin and calcium in the hemodialysis patients. Am J Kidney Dis 1993 ; 21:292-9.
52. Messa P, Mioni G, Turrin D, Guerra UP. The calcitonin relation curve and calcitonin secretory parameters in renal patients with valuable degrees of renal function. Nephrol Dial Transplant 1995 ; 10:2259-65.
53. Bover J, Jara A, Trinidad P, Rodriguez M, Martin-Malo A, Felsenfeld AJ. The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia. Kidney Int 1994 ; 46:310-17.
54. Gonzalez EA, Martin KJ. Coordinate regulation of the expression of PTH/PTH rP receptor by PTH and calcitriol in UMR 106-01 osteoblast-like cells. Kidney Int 1996 ; 50:63-70.
55. Ureña P, Mannstadt M, Hruby M, Ferreira A, Segre G, Drüeke T. Parathyroidectomy does not prevent the renal PTH/PTH rP receptor down regulation in uremic rats. Kidney Int 1995 ; 47:1797-1805.
56. Fournier A, Idrissi A, Sebert JL, Gueris J, Garabedian M. Preventing renal bone disease in moderate renal failure with CaCO3 and 25OH vitamine D3. Kidney Int 1988 ; 33(suppl24):S178-9.
57. 3 in non dialyzed patients with chronic renal failure. Am J Kidney Dis 1995 ; 25:879-86.
58. 3 for the control of hyperparathyroïdism and hyperaluminemia in patients on maintenance dialysis. Nephron 1985 ; 39:309-15.
59. Indriason OS, Quarles D. Prospective randomized trial comparing CaCO3 with oral and intravenous calcitriol in hemodialysis patients with uremic hyperparathyroidism. J Am Soc Nephrol 1997 ; 8:575 A.
60. Antonsen JE, Sherrard DJ, Andress DL. G A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Kidney Int 1998 ; 53:223-7.
61. Rude RK. Parathyroid function in magnesium deficiency. In: The Parathyroids. Bilezikian JP ed. Raven Press, New York, 1994 ; 829-42.